Dalbavancin as chronic antibiotic suppression therapy for left ventricular assist device driveline infection due to methicillin-resistant <i>Staphylococcus aureus</i>: a case report-Reference-Cited by-同舟云学术

Dalbavancin as chronic antibiotic suppression therapy for left ventricular assist device driveline infection due to methicillin-resistant Staphylococcus aureus: a case report

Published:2022-10-25 Issue: Volume: Page:1-5
ISSN:1120-009X
Container-title:Journal of Chemotherapy
language:en
Short-container-title:Journal of Chemotherapy

Author:

Pallotto Carlo¹^ORCID,Tordi Sara¹,Pantanella Romina²,Rosignoli Daniele¹,Francisci Daniela¹

Affiliation:

1. Infectious Diseases Clinic, Santa Maria della Misericordia Hospital, Department of Medicine and Surgery, University of Perugia, Perugia, Italy

2. Department of Cardiac Surgery, Santa Maria della Misericordia Hospital, Perugia, Italy

Publisher

Informa UK Limited

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Oncology

Link

https://www.tandfonline.com/doi/pdf/10.1080/1120009X.2022.2136426

Reference12 articles.

1. In Full Flow: Left Ventricular Assist Device Infections in the Modern Era

2. Left Ventricular Assist Device Infections: A Systematic Review

3. Efficacy and safety of chronic antimicrobial suppression therapy for left ventricular assist device driveline infections: A single‐center descriptive experience

4. Left ventricular assist device-related infections: a multicentric study

5. Real-World Use of Dalbavancin in the Era of Empowerment of Outpatient Antimicrobial Treatment: A Careful Appraisal Beyond Approved Indications Focusing on Unmet Clinical Needs

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic antibiotic suppressive therapy with dalbavancin: a case series;Journal of Chemotherapy;2024-05-07

2. Long-term Dalbavancin for Suppression of Gram-Positive Chronic Left Ventricular Assist Device Infections;Open Forum Infectious Diseases;2023-11-01

3. Cotrimoxazole;Reactions Weekly;2023-09-30

4. Dalbavancin as suppressive antibiotic therapy in patients with prosthetic infections: efficacy and safety;Frontiers in Pharmacology;2023-06-28